hey it’s tim… you’re not on my list?

Investor Alert: Using DNA This Young Company Has Big Potential to "X" out Cancer - Literally ...

Dear Reader, There's a tiny X-shape in your DNA that could change everything we know about aging and cancer. It's called a telomere, and it's the target of a groundbreaking new treatment by an up-and-coming stock that Wall Street is loading up on! Vanguard has 500,000 shares Blackrock 78,000 shares Halter Ferguson a whopping 738,000 shares 22 major banks in all holding this $3 stock This under-the-radar firm is pioneering a first-of-its-kind therapy that could soon disrupt a $59 billion market. And here's the kicker: they could be on the brink of FDA approval. Don't miss your chance on a stock that could skyrocket. Click here to get the full name and ticker symbol on what could be the investment opportunity of 2024. Sincerely, EDITOR

 

 

Notice: Please understand that by opting out from future emails from this advertiser, you are transferring or authorizing the transfer of your email address to the advertiser listed above. Zacks has no control over how your email address is used by the advertiser or other third parties. Accordingly, Zacks disclaims all responsibility and liability arising from the subsequent use of your email address that is made possible by your submission of your email address above. You are receiving this email from Zacks Investment Research because you chose to receive messages from Zacks’ partners on the Zacks web site(s). Please note that Zacks does not produce or endorse this product, and assumes no responsibility for the use thereof. Your privacy is important to us. Click here to see our Privacy Policy: https://www.zacks.com/privacy.php If you do not wish to receive further email solicitations from Zacks on behalf of its partners, please click here to unsubscribe. Zacks Investment Research 10 S. Riverside Plaza, Suite 1600 Chicago, IL 60606